USPTO serial 87431283
SYNAPSET
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 11, 2018
- Examiner
- BEDNARZ, DUSTIN THOMAS
- Law office
- Historical data usage
What this means
Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary. Calendar the 10-year Section 8 and 9 combined renewal.
Need help with SYNAPSET?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Sherbrooke, CA
Sherbrooke, CA
Sherbrooke, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jess M. Collen
Jess M. Collen Rothwell, Figg, Ernst & Manbeck, P.C.3 Manhattanville RoadPurchase, NY 10577United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Beverages containing fish oils, minerals, vitamins, for use as a nutritional supplement; ] Chemical preparations for pharmaceutical or medical purposes, namely, for attention-deficit/hyperactivity disorder (ADHD) [ , autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Delivery agents in the form of powder, liquid, capsules, tablets, gel that facilitate the delivery of nutritional supplements; Dietary and nutritional supplements; ] Dietary [ and nutritional ] supplements containing fish oils, minerals, vitamins [ , plant oil; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary food supplements; Dietary supplement beverage for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Dietary supplement drink mixes; Dietary supplemental drinks; Dietary supplemental drinks in the nature of vitamin and mineral beverages; Dietary supplements; Dietary supplements also containing minerals, vitamins, oils; Dietary supplements for human consumption ] ; Dietary supplements for attention-deficit/hyperactivity disorder (ADHD) [ , autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Dietetic beverages adapted for medical use; Dietetic foods adapted for medical purposes; Dietetic foods and beverages adapted for medical use; Dietetic foods for treating attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Edible fish oils, mineral preparations, vitamins, and medicinal plant oils adapted for medical use; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powder, liquid, capsules, tablets, gel that facilitate the delivery of pharmaceutical preparations; Edible fish oils for medical purposes; Food supplements; Food supplements for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Gummy vitamins; Liquid nutritional supplement; Liquid vitamin supplements; Medicaments for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson 's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Medicated water for the treatment of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Medicinal drinks; Migraine treatment preparations; Mineral food supplements; Mineral nutritional supplements; Mineral supplements; Mineral, vitamin, or nutritionally enhanced water for medical purposes; Mixed vitamin preparations; Multi-vitamin preparations ] ; Multivitamin preparations; [ Natural dietary supplements; Natural dietary supplements for the treatment of attentiondeficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Natural supplements for treating depression and anxiety; Nutraceuticals for the treatment of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Nutraceuticals for use as a dietary supplement; ] Nutraceuticals for use as a dietary supplement for attention-deficit/hyperactivity disorder (ADHD) [ , autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Nutritional and dietary supplements formed and packaged as bars; Nutritional supplement energy bars; Nutritional supplement shakes; Nutritional supplements ] ; Nutritional supplements consisting primarily of Omega3 oil, vitamins, vitamin B6, minerals, zinc, magnesium [ ; Nutritional supplements for attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Nutritional supplements in the form of powder, liquid, capsules, tablets, gel; Nutritional supplements, namely, probiotic compositions; Nutritionally fortified beverages for medical purposes; Nutritionally fortified water for medical purposes; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment and prevention of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Pharmaceutical preparations for the treatment of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Pharmaceutical preparations for treating chemical imbalances; Powdered nutritional supplement concentrate; Powdered nutritional supplement drink mix; Powdered nutritional supplement drink mix and concentrate; Powdered nutritional supplement drink mix containing fish oils, vitamins, minerals, plant oils; Therapeutic pharmaceutical for the treatment of attention-deficit/hyperactivity disorder (ADHD), autism, depression, cognitive impairment, Alzheimer's disease, Parkinson's disease, anxiety, mood disorder, nervous degenerative trouble, migraine; Vitamin and mineral formed and packaged as bars; Vitamin and mineral preparations for medical use; Vitamin and mineral supplements; Vitamin and mineral supplements for mixing with food and beverages; Vitamin B preparations; Vitamin fortified beverages for medical purposes; Vitamin preparations; Vitamin supplements; Vitamin tablets; Vitamins; Vitamins and vitamin preparations ] | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 16, 2025 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Jun 16, 2025 | 8.OK | REGISTERED - SEC. 8 (6-YR) ACCEPTED | The USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline. |
| Jun 16, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 7, 2025 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Sep 11, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Aug 20, 2019 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Aug 20, 2019 | CANT | CANCELLATION TERMINATED NO. 999999 | — |
| Aug 20, 2019 | CAND | CANCELLATION DENIED NO. 999999 | — |
| Oct 1, 2018 | PETC | CANCELLATION INSTITUTED NO. 999999 | — |
| Sep 11, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 26, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 26, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 6, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 23, 2018 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| May 18, 2018 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| May 14, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 18, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 18, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 14, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 16, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 16, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 16, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 16, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 16, 2018 | RFTP | REMOVED FROM TEAS PLUS | — |
| Mar 5, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 5, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 28, 2018 | ALIE | ASSIGNED TO LIE | — |
| Feb 16, 2018 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Feb 15, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 15, 2018 | PETG | PETITION TO REVIVE-GRANTED | — |
| Feb 15, 2018 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Aug 3, 2017 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 3, 2017 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Aug 3, 2017 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Jul 27, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| May 5, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 3, 2017 | NWAP | NEW APPLICATION ENTERED | — |